The buyout dovetails with Zimmer Biomet’s joint program with the U.S. Defense Dept. to develop a transcutaneous system for anchoring external prosthetic limbs.
Developed over a 10-year span by Dr. Ronald Hugate Jr., a former U.S. military surgeon, the Ortho Transmission technology is designed to eliminate the skin-to-socket interface used with traditional prostheses by connecting directly to the patient’s bones. Zimmer Biomet said it plans to launch a clinical trial of the technology using the Ortho Transmission designs.
“Transcutaneous osseous integrated technology represents a fundamental innovation in limb replacement, and Zimmer Biomet is proud to leverage our musculoskeletal expertise to significantly improve the quality of life of amputee patients living in the United States and around the world,” vice president Todd Davis said in prepared remarks. “Our leading research & development capabilities, combined with our proprietary Trabecular Metal material to support bone ingrowth and vascularization, represents the ideal platform to accelerate the commercialization of this implant. This acquisition also perfectly aligns with our broad-based focus on clinically relevant innovations.”
“We are truly excited to partner with the world leader in musculoskeletal innovation and we look forward to accelerating this ongoing work in order to bring this pioneering technology to market,” added Ortho Transmission general manager D.C. Hoffman.